Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Stage Iv”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01216436
What this trial is testing

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Duke University 2
Early research (Phase 1)Study completedNCT00019175
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Study completedNCT00005971
What this trial is testing

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Ended earlyNCT04337931
What this trial is testing

Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable MelanomaMetastatic MelanomaCancer+3 more
Apexigen America, Inc. 45
Very early researchEnded earlyNCT03893019
What this trial is testing

MB-CART20.1 Melanoma

Who this might be right for
Melanoma (Skin)
Miltenyi Biomedicine GmbH 9
Testing effectiveness (Phase 2)Ended earlyNCT00612222
What this trial is testing

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Not applicableActive Not RecruitingNCT07022457
What this trial is testing

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

Who this might be right for
Metastatic Melanoma, BRAF V600 Mutation Positive
Pierre Fabre Ltd 50
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT00086866
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 165
Testing effectiveness (Phase 2)Study completedNCT01743157
What this trial is testing

Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
California Pacific Medical Center Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT00861913
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Ended earlyNCT01970527
What this trial is testing

Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
University of Washington 23
Testing effectiveness (Phase 2)Study completedNCT00249262
What this trial is testing

Taxoprexin Treatment for Advanced Skin Melanoma

Who this might be right for
Metastatic Melanoma
American Regent, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT02142335
What this trial is testing

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

Who this might be right for
Malignant Melanoma of Skin Stage IIIMetastatic Melanoma
California Cancer Assocaties for Research & Excellence 17
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableEnded earlyNCT02744209
What this trial is testing

Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

Who this might be right for
Stage IV Melanoma
Mayo Clinic 17
Testing effectiveness (Phase 2)Ended earlyNCT01942993
What this trial is testing

The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

Who this might be right for
Melanoma
Philip Friedlander 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101134
What this trial is testing

Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Next Page